The absorption enhancer sodium deoxycholate promotes high gene transfer in skeletal muscles - CNRS - Centre national de la recherche scientifique Accéder directement au contenu
Article Dans Une Revue International Journal of Pharmaceutics Année : 2017

The absorption enhancer sodium deoxycholate promotes high gene transfer in skeletal muscles

Résumé

Gene delivery to skeletal muscle is a promising strategy for the treatment of muscle disorders and for the systemic secretion of therapeutic proteins. In addition, muscle is an attractive target tissue because it is easily accessible. However, very few synthetic vectors proved capable of surpassing naked DNA mediated muscle gene transfer. In fact, only neutral copolymers, in particular poloxamers, demonstrated capacities to increase transgene expression in skeletal muscles. Here, we studied in vitro and in vivo behaviour of different bile salts. We report that sodium deoxycholate (DOC) and derivatives thereof increase after intramuscular injection by more than 100-fold the levels of the reporter gene luciferase compared to naked DNA. Using a LacZ expression cassette, we found that more than 20% of the muscle fibers expressed the reporter gene. Prolonged expression of a secreted reporter gene derived from a natural murine alkaline phosphatase enzyme could be documented. Altogether, our results demonstrate that bile salts belong to the most efficient chemicals identified so far for skeletal muscle gene transfer. Importantly, since these compounds are naturally found in the body, there is no risk of immune response against them and in addition several bile salts are already used in human medicine. Bile salt mediated muscle gene transfer may thus have broad applications in gene therapy.
Fichier non déposé

Dates et versions

hal-02880992 , version 1 (25-06-2020)

Identifiants

Citer

C. Leborgne, D. Alimi-Guez, N. El Shafey, L. Van Wittenberghe, P. Bigey, et al.. The absorption enhancer sodium deoxycholate promotes high gene transfer in skeletal muscles. International Journal of Pharmaceutics, 2017, 523 (1), pp.291-299. ⟨10.1016/j.ijpharm.2017.03.020⟩. ⟨hal-02880992⟩
18 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More